MedPath

Prospective Analysis to Detect Myometrial Cells in Peritoneal Washing in Patients Undergoing Minimally Invasive Hysterectomy Using Containment Bag at University of Texas Medical Branch

Recruiting
Conditions
Hysterectomy
Interventions
Diagnostic Test: Peritoneal washings
Registration Number
NCT05955651
Lead Sponsor
The University of Texas Medical Branch, Galveston
Brief Summary

The Aim of the study is to determine endometrial/myometrial spillage during total laparoscopic hysterectomy with manual morcellation.

Detailed Description

This will be a single institution prospective analysis study. The study will include 50 women who are undergoing minimally invasive hysterectomy. Surgery will be done from 08/01/2023 to 08/01/2024, for benign conditions with uterus that is \> 10 cm that requires contained bag morcellation such as (Fibroids, Adenomyosis, Endometriosis, abnormal uterine bleeding, pelvic organ prolapse). Three Samples of peritoneal washings will be collected and send to pathology. First washing will be collected after entering the abdominal cavity, second washing will be done after completion of hysterectomy and containment of the uterus in the bag, and the third washing after scalpel morcellation of the uterus in the containment bag and extraction within the bag. Extraction of the specimen will be done either through the vagina or through a mini laparotomy incision (2-3 cm).

Recruitment & Eligibility

Status
RECRUITING
Sex
Female
Target Recruitment
50
Inclusion Criteria
  1. Women undergoing minimally invasive Laparoscopic / Robotic hysterectomy for presumably benign conditions such as (fibroids, adenomyosis, endometriosis, pelvic organ prolapse, abnormal uterine bleeding)
  2. Large size uterus measuring more than 10 cm on US requiring cold knife morcellation within the Alexis containment bag, surgery will be done by designated surgeon at UTMB from 08/01/2023 to 08/01/2024.
  3. Women 18 years and older
  4. Subjects must be able to provide consents.
  5. Normal endometrial biopsy.
  6. Normal cervical cancer screening
Exclusion Criteria
  1. Known Gynecological malignancy.
  2. Endometrial biopsy with endometrial intraepithelial hyperplasia.
  3. History of exposure to pelvic radiation
  4. Post-menopausal patients
  5. Emergency hysterectomy
  6. TDC patients
  7. Patient less than 18 years old

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Pelvic washingsPeritoneal washingsThree Samples of peritoneal washings will be collected and send to pathology. looking for myometrial cell spillage at three designated points in surgery. 1st before hysterectomy, 2nd after hysterectomy, and 3rd after morcellation and extraction of the uterus out of the abdominal cavity.
Primary Outcome Measures
NameTimeMethod
Detection of myometrial cell spillage in peritoneal washingPelvic washing samples will be sent the pathology lab to be examined within 2 days of the surgery.

To evaluate potential cell spillage from morcellated tissue, the 3 peritoneal washings collected will be sent to cytology lab to be examined for the presence of smooth muscle cells

Secondary Outcome Measures
NameTimeMethod
Timing of myometrial cell spillage during hysterectomyPelvic washing samples will be sent the pathology lab to be examined within 2 days of the surgery.

To determine at what stage myometrial cell spillage happens during a minimally invasive hysterectomy surgery (before, after completion of the hysterectomy or after morcellation and tissue extraction)

Trial Locations

Locations (1)

University of Texas Medical branch

🇺🇸

Galveston, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath